Related Experiment Video
Updated: Feb 12, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Comorbidities in aging patients with sickle cell disease
1Cardeza Foundation for Hematologic Research, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Insights
Sickle cell disease (SCD) survival has improved, but aging patients now face comorbidities. This review identifies these conditions to ensure better long-term health outcomes for individuals with SCD.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Sickle cell disease (SCD) is a complex genetic disorder with diverse molecular and clinical manifestations.
- Acute complications include vaso-occlusive crises and acute chest syndrome, while chronic issues involve avascular necrosis and leg ulcers.
- Therapeutic advances have significantly improved patient survival, leading to an aging SCD population.
Purpose of the Study:
- To identify and characterize comorbidities in elderly patients with sickle cell disease.
- To differentiate these comorbidities from the underlying SCD to guide appropriate management.
- To inform strategies for maintaining improved survival and quality of life in aging SCD patients.
Main Methods:
- This is a review article, synthesizing existing literature on SCD comorbidities in the elderly.
- The review focuses on identifying conditions common in the aging general population that may be influenced by or co-occur with SCD.
- Emphasis is placed on distinguishing primary SCD complications from age-related comorbidities.
Main Results:
- Improved survival in SCD has introduced age-related comorbidities, posing a new challenge to patient management.
- These comorbidities can potentially offset the gains in survival achieved through modern therapies.
- Differentiating comorbidities from SCD is crucial for effective treatment planning.
Conclusions:
- Aging individuals with SCD are experiencing comorbidities that require careful identification and management.
- Proactive identification and differentiation of comorbidities are essential for sustaining improved survival rates in SCD.
- Further research and clinical strategies are needed to address the complex health needs of the aging SCD population.
Abstract:
Sickle cell disease (SCD) in general and sickle cell anemia in particular is a highly complex disorder both at the molecular and clinical levels. Although the molecular lesion is a single-point mutation, the sickle gene is pleiotropic in nature causing multiple phenotypic expressions that constitute the various complications of the disease. Moreover, despite the fact that SCD is a chronic malady, its manifestations are both acute and chronic. The former include, among other things, the recurrent vaso-occlusive crises (its hallmark) and acute chest syndrome. The chronic complications include most commonly avascular necrosis and leg ulcers. Currently, survival of patients with SCD has improved dramatically thanks to newborn screening, antibiotic prophylaxis, better vaccine, safer blood transfusion and the use of hydroxyurea. It is the advent of these therapies that improved the survival. This improvement, however, introduced a third dimension of the disease: comorbidities that occur in aging people in the general population. There is concern that the gain in survival may be offset by the comorbidities. Thus it is the purpose of this review to identify the comorbidities in the elderly with SCD and differentiate them from the basis disease to implement proper therapies so that better survival could be maintained.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

